跳至主要内容
临床试验/NCT01767428
NCT01767428已完成1 期

A Pharmacokinetic Study to Evaluate the Rate and Extent of Absorption of Paracetamol From Two Formulations in an Indian Population.

GlaxoSmithKline0 个研究点目标入组 30 人开始时间: 2010年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
30
主要终点
Cmax

研究概览

简要总结

A pharmacokinetic study in healthy volunteers comparing two formulations of paracetamol fast release in fasted state.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Healthy male volunteers aged 18-55yrs willing to give written informed consent for the study
  • BMI must be within the range 18.5 - 24.9 kg/m^2
  • Participant with a minimum weight of 50 kg

排除标准

  • Participant with current or recurrent disease that could affect the action, absorption or disposition of the study medication or clinical or laboratory assessments (e.g. hepatic disorders, renal insufficiency, congestive heart failure)
  • Participant with known or suspected intolerance or hypersensitivity to the study materials
  • Participant who are vegetarian
  • Participant smoking more than five cigarettes a day

研究组 & 干预措施

Experimental Paracetamol Tablet

Experimental

Experimental paracetamol tablet (500 milligrams [mg]) administered with 240 milliliters (mL) of water.

干预措施: Paracetamol (Drug)

Standard Paracetamol Tablet (500 mg)

Active Comparator

Standard paracetamol tablet (500 mg) administered with 240 mL of water.

干预措施: Paracetamol (Drug)

结局指标

主要结局

Cmax

时间窗: Blood samples drawn at 15 minutes pre-dose, then at 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 75, 90 minutes post dose and then at 2, 3, 4, 6, 8, 10, 12 hrs post dose.

Maximum plasma concentration of paracetamol.

AUC (0-t)

时间窗: Blood samples drawn at 15 minutes pre-dose, then at 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 75, 90 minutes post dose and then at 2, 3, 4, 6, 8, 10, 12 hrs post dose.

Area under the plasma concentration time curve from zero and extrapolated to the time of last quantifiable sample.

AUC (0-inf)

时间窗: Blood samples drawn at 15 minutes pre-dose, then at 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 75, 90 minutes post dose and then at 2, 3, 4, 6, 8, 10, 12 hrs post dose.

Area under the plasma concentration time curve from zero and extrapolated to infinite time.

次要结局

  • Tmax(Blood samples drawn at 15 minutes pre-dose, then at 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 75, 90 minutes post dose and then at 2, 3, 4, 6, 8, 10, 12 hrs post dose.)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

Pharmacokinetic Study to Compare Two Formulations of... | 临床试验